Haoyue Capital, an industrial investment bank focusing on China's healthcare, recently released the "2023 7th Healthcare Investment Excellence List", and Jingyu Medical was awarded the "Best Innovative Medical Device Enterprise of 2022" award.
As a gazelle enterprise in the field of brain science research in China, SceneRay Medical has been certified by the Ministry of Industry and Information Technology as a specialized and innovative "little giant" enterprise and has been rated as a potential landmark enterprise in the pharmaceutical industry by Suzhou.
In the highly promising field of brain science, SceneRay Medical insists on the path of independent innovation, developing domestically produced brain pacemakers with completely independent intellectual property rights, and has won many honors including the Second Prize of National Science and Technology Innovation, the China Medical Industry Development and Innovation Award, etc.
In the future, SceneRay Medical will live up to expectations and continue to work hard, resonate with technological innovation, keep pace with market demand, and polish out more accurate and reliable treatment plans and products for brain functional diseases, and reshape the healthy life of patients!